Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ATLCAR.CD30 cells |
Trade Name | |
Synonyms | CAR.CD30-expressing Autologous T Lymphocytes |
Drug Descriptions |
ATLCAR.CD30 cells are autologous T-lymphocytes engineered to express a chimeric antigen receptor that targets CD30, potentially leading to immune response against CD30-positive tumor cells (PMID: 30841880). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C116738 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATLCAR.CD30 cells | ATLCAR.CD30 cells | 0 | 4 |
ATLCAR.CD30 cells + ATLCAR.CD30.CCR4 cells | ATLCAR.CD30 cells ATLCAR.CD30.CCR4 cells | 0 | 1 |
ATLCAR.CD30 cells + Cyclophosphamide + Fludarabine | ATLCAR.CD30 cells Cyclophosphamide Fludarabine | 0 | 2 |
ATLCAR.CD30 cells + Nivolumab | ATLCAR.CD30 cells Nivolumab | 0 | 1 |